Longeveron (LGVN) Net Margin (QoQ) (2020 - 2026)
Longeveron (LGVN) Net Margin (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Longeveron |
20.35 Bn |
20.33 Bn |
264,000.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
29,176.00 |
| Dec 31, 2025 |
377,930.00 |
| Sep 30, 2025 |
-367,966.00 |
| Jun 30, 2025 |
-23,130.00 |
| Mar 31, 2025 |
-68,306.00 |
| Dec 31, 2024 |
-8,584.00 |
| Sep 30, 2024 |
195,478.00 |
| Jun 30, 2024 |
-179,938.00 |
| Mar 31, 2024 |
882,190.00 |
| Dec 31, 2023 |
-563,225.00 |
| Sep 30, 2023 |
-134,061.00 |
| Jun 30, 2023 |
-90,507.00 |
| Mar 31, 2023 |
199,315.00 |
| Dec 31, 2022 |
156,053.00 |
| Sep 30, 2022 |
-433,821.00 |
| Jun 30, 2022 |
1,150.00 |
| Mar 31, 2022 |
101,237.00 |
| Dec 31, 2021 |
18,499.00 |
| Sep 30, 2021 |
-107,907.00 |
| Jun 30, 2021 |
-11,590.00 |
